Additional priority legislation being supported and opposed include:
340B Drug Pricing Program: Support for 340B program reforms through House Bill 2371 (see also PhRMA-backed reforms proposed in HB5421 / SB3878; and click here for an infographic and podcast discussion of the competing 340B proposals) (UPDATE: click here for review of the final negotiated compromise)
Menopause-Related Care: Promotion of menopause education through Senate Bill 3325, which integrates into current implicit bias continuing education requirements and is an initiative of the Lt. Governor (see also HB5284 and SB3688, which contain additional menopause-related policy proposals that may be combined into a larger menopause equity package this session) (UPDATE: all three menopause-related bills passed after amendments focusing each bill on separate but related areas of education in medical school, optional continuing medical education, and public education and access enhancements)
Prior Authorization: Amending House Bill 4709 to preserve all 2021 prior authorization protections won by IAFP and healthcare coalition allies; (HB 4709 is an initiative of the National Coalition of Insurance Legislators (NCOIL), which also utilizes American Medical Association (AMA) model law provisions finalized at the national level in 2025) (UPDATE: NCOIL model language did not move forward given Illinois already having comprehensive prior authorization framework since 2021)